Overview

Aspirin-Myocardial Infarction Study (AMIS)

Status:
Completed

Trial end date:
1979-08-01

Target enrollment:

Participant gender:

Summary

To determine whether the daily administration of 1 gm of aspirin to individuals with a documented myocardial infarction would result in a significant reduction in mortality over a three year period.

Phase:

Phase 3

Details

Lead Sponsor:

National Heart, Lung, and Blood Institute (NHLBI)

Treatments:

Aspirin